CV Lattes
ResearcherID
ORCID
Google Scholar Citations
Universidade São Francisco (USF). Campus Bragança Paulista (Institutional affiliation from the last research proposal) Birthplace: Brazil
He holds a Bachelors degree in Biological Sciences from São Paulo State University (Unesp), and a Masters degree in Child and Adolescent Health and a PhD in Sciences from the University of Campinas (Unicamp). He completed a postdoctoral fellowship with an international exchange period at the University of Lisbon, under the supervision of Prof. Margarida D. Amaral. In 2018, he undertook postgraduate training at Harvard University, completing the course Principles and Practice of Clinical Research, where he was awarded for outstanding academic performance. He is currently a Professor in the Stricto Sensu Graduate Program in Health Sciences at São Francisco University, which is ranked with the highest CAPES score (Grade 7).He has published more than 250 scientific papers, primarily in the fields of genetics and epidemiology. He serves as a peer reviewer for over 300 national and international journals and is a member of the editorial board of several scientific periodicals. Throughout his academic career, he has received more than 60 awards for research excellence and academic achievement, including distinctions for academic performance during his undergraduate studies. He has participated in hundreds of scientific meetings, presenting research findings. In 2015, he was recognized as a leading figure in medical genetics by Whos Who in This World. Furthermore, he was listed among the worlds most influential researchers by Elsevier in 2022, 2023, 2024, and 2025, and by ScholarGPS in 2024, in the areas of COVID-19, pandemics, and global research impact.He was formally recognized as a collaborating researcher at the Center for Research in Pediatrics (CIPED), in accordance with Resolution No. 715/2015 (Process No. 02P24698/2015).He maintains active research collaborations with internationally renowned institutions, including the Catholic University of Murcia, the University of Washington, Indiana University, and the University of California. During the COVID-19 pandemic, he participated in large-scale international collaborative studies with the NIHR Global Health Research Unit on Global Surgery. Notable contributions include: (a) Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study, published in Anaesthesia and included in the Guinness World Records; and (b) Elective surgery system strengthening: development, measurement, and validation of the Surgical Preparedness Index across 1,632 hospitals in 119 countries, conducted by the NIHR Global Health Unit on Global Surgery COVIDSurg Collaborative and published in The Lancet.He has supervised more than 50 undergraduate research, masters, and doctoral students. Currently, he supervises 20 students, many of whom are supported by competitive research grants from the Brazilian National Council for Scientific and Technological Development (CNPq) and the São Paulo Research Foundation (FAPESP). (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Introduction: The possibility that asthma is not a risk factor for the worst outcomes due to coronavirus disease (COVID-19) is encouraged. The increase in Th2 response dominance can downregulate the late phase of hyperinflammation, which is typically the hallmark of more severe respiratory viral infections, alongside lower angiotensin-converting enzyme receptors in patients with asthma du…
Introduction: The treatment of most severe COVID-19 patients included the large-scale use of sedatives and analgesics - possibly in higher doses than usual - which was reported in the literature. The use of drugs that decrease mortality is necessary and opioids are important agents in procedures such as orotracheal intubation. However, these drugs seem to have been overestimated in the CO…
Cystic fibrosis (CF) is a recessive genetic condition, predominantly observed in the Caucasian population, that continues to challenge medicine despite recent advances. Pathogenic variants in the CFTR gene (Cystic Fibrosis Transmembrane Conductance Regulator) are responsible for the manifestation of the disease, resulting in a range of phenotypes associated with different genetic variants…
Introduction: Berardinelli-Seip syndrome is classified as one of the 4 types of lipodystrophies, a rare recessive genetic condition associated with the total absence of subcutaneous adipose tissue. It manifests in 4 different phenotypes, depending on the pathogenic variant, leading to various metabolic disorders in affected individuals, such as diabetes mellitus, hypertriglyceridemia, and…
Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) triggered a global pandemic known as coronavirus disease (COVID-19), affecting the health and lives of millions of people. Brazil reported many diagnosed cases and deaths, along with the concurrent collapse of the healthcare system. COVID-19 presents a broad spectrum of phenotypes and can range from mild symptoms t…
Introduction: The epidemic of the new coronavirus [Coronavirus Disease (COVID)-19)] began in Wuhan Province, China, in December 2019, as a new form of pneumonia that progressed with dry fever and fatigue, in addition to occasional gastrointestinal symptoms. By July 2021, the new coronavirus (SARS-CoV-2) was responsible for more than 185 million cases and 4 million deaths worldwide, a numb…
Introduction: Few studies have described that COVID-19 in patients with Down Syndrome (DS) is associated with longer intubation time and higher mortality rates, however, most of these studies have their conclusions based on a small sample size. In this context, due to the low sample size, the real impact of the COVID-19 has on DS patients still needs to be better clarified. Therefore, the…
(Only some records are available in English at this moment)